James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 17,000 shares at $28.47 ($484K) on 2017-12-29, disclosed to the SEC on 2017-12-29.
Open-market purchase of $484k RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |
| RETA | BUY | 2017-06-23 | $30.0M | — | Filing → |